Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ho, Anthony D."'
Autor:
Dietrich, Sascha, Oleś, Małgorzata, Lu, Junyan, Sellner, Leopold, Anders, Simon, Velten, Britta, Wu, Bian, Hüllein, Jennifer, Da Silva Liberio, Michelle, Walther, Tatjana, Wagner, Lena, Rabe, Sophie, Ghidelli-Disse, Sonja, Bantscheff, Marcus, Oleś, Andrzej K, Słabicki, Mikołaj, Mock, Andreas, Oakes, Christopher C, Wang, Shihui, Oppermann, Sina, Lukas, Marina, Kim, Vladislav, Sill, Martin, Benner, Axel, Jauch, Anna, Sutton, Lesley Ann, Young, Emma, Rosenquist, Richard, Liu, Xiyang, Jethwa, Alexander, Lee, Kwang Seok, Lewis, Joe, Putzker, Kerstin, Lutz, Christoph, Rossi, Davide, Mokhir, Andriy, Oellerich, Thomas, Zirlik, Katja, Herling, Marco, Nguyen-Khac, Florence, Plass, Christoph, Andersson, Emma, Mustjoki, Satu, Von Kalle, Christof, Ho, Anthony D, Hensel, Manfred, Dürig, Jan, Ringshausen, Ingo, Zapatka, Marc, Huber, Wolfgang, Zenz, Thorsten
As new generations of targeted therapies emerge and tumor genome sequencing discovers increasingly comprehensive mutation repertoires, the functional relationships of mutations to tumor phenotypes remain largely unknown. Here, we measured ex vivo sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7da476c4f9dd12568bc9ecbdd35e25ef
Autor:
Dietrich S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Oleś M; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Lu J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Sellner L; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Anders S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Velten B; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Wu B; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Hüllein J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., da Silva Liberio M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Walther T; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Wagner L; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Rabe S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Ghidelli-Disse S; Cellzome, Heidelberg, Germany., Bantscheff M; Cellzome, Heidelberg, Germany., Oleś AK; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Słabicki M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Mock A; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Oakes CC; Division of Hematology, Departments of Internal Medicine and Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Centre, Heidelberg, Germany., Wang S; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Oppermann S; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lukas M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Kim V; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Sill M; Division of Biostatistics, German Cancer Research Centre, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Centre, Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Young E; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Liu X; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Jethwa A; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lee KS; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lewis J; European Molecular Biology Laboratory (EMBL), Chemical Biology Core Facility, Heidelberg, Germany., Putzker K; European Molecular Biology Laboratory (EMBL), Chemical Biology Core Facility, Heidelberg, Germany., Lutz C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Rossi D; Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mokhir A; Friedrich-Alexander-University of Erlangen-Nürnberg, Department of Chemistry and Pharmacy, Organic Chemistry II, Erlangen, Germany., Oellerich T; Hematology/Oncology, Department of Medicine, Johann Wolfgang Goethe University, Frankfurt, Germany; Department of Haematology, Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Zirlik K; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology/Oncology, University Hospital Freiburg, Freiburg, Germany and Tumorzentrum ZeTuP Chur, Chur, Schweiz., Herling M; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Nguyen-Khac F; INSERM U1138, Université Pierre et Marie Curie-Paris and Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Paris, France., Plass C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Andersson E; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland and Department of Hematology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland and Department of Hematology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland., von Kalle C; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Heidelberg Centre for Personalized Oncology, DKFZ-HIPO, DKFZ, Heidelberg, Germany., Ho AD; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Hensel M; Mannheim Oncology Practice, Mannheim, Germany., Dürig J; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology, University Hospital Essen, Essen, Germany., Ringshausen I; Department of Hematology, University of Cambridge, Cambridge, United Kingdom., Zapatka M; Division of Molecular Genetics, German Cancer Research Centre, Heidelberg, Germany., Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Zenz T; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology, University of Zürich, Zürich, Switzerland.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Jan 02; Vol. 128 (1), pp. 427-445. Date of Electronic Publication: 2017 Dec 11.